Summary
The main challenges for application of gene therapy to patients are poor selectivity in vector targeting, insufficient gene transfer, and great difficulties in systemic treatment in association with safety concerns for particular vector systems. For success in gene therapy, safe, applicable, and efficient transfer technologies are required. Because of the complex nature of targeted vector delivery to the tumor, our strategy for gene therapy is focused on the development of local nonviral gene transfer. This approach of local interference with tumor growth and progression could contribute to better control of the disease. Transfer of naked DNA is an important alternative to liposomal or viral systems. Different physical procedures are used for improved delivery of naked DNA into the target cells or tissues in vitro and in vivo. Among the various nonviral gene delivery technologies, jet-injection is gaining increased attractiveness, because this technique allows gene transfer into different tissues with deep penetration of naked DNA by circumventing the disadvantages associated with, e.g., viral vectors. The jet-injection technology is based on jets of high velocity for penetration of the skin and underlaying tissues, associated with efficient transfection of the affected area. The jet-injection technology has been successfully applied for in vivo gene transfer in different tumor models. More importantly, the efficacy and safety of jet-injection gene transfer have recently been investigated in a phase I clinical trial.
Similar content being viewed by others
References
1. Wolff J. A., Malone R. W., Williams P., Chong G., Acsadi A., Jani A., Felgner P. L. (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465–1458.
2. Herweijer H., Wolff J. A. (2003) Progress and prospects: naked DNA transfer and therapy. Gene Ther 10: 453–458.
3. Niidome T, Huang L. (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9: 1647–1652.
4. Romano G. (2007) Current development of nonviral-mediated gene transfer. Drug News Perspect 20: 227–231.
5. Edelstein M. L., Abedi M. R., Wixon J. (2007) Gene therapy clinical trials worldwide to 2007 – an update. J. Gene Med 9: 833–842.
6. Klinman D. M., Conover J., Leiden J. M., Rosenberg S. A., Sechler J. M. G. (1999) Safe and effective regulation of hematocrit by gene gun administration of an erythropoietin-encoding DNA plasmid. Hum Gene Ther 10: 659–665.
7. Sikes M. L., O'Malley B. W., Finegold M. J., Ledley F. D. (1994). In vivo gene transfer into rabbit thyroid follicular cells by direct DNA injection. Hum Gene Ther 6: 837–844.
8. Yang N. S., Burkholder J., Roberts B., Martinell B., McCabe D. (1990) In vivo and in vitro gene transfer to mammalian cells by particle bombardment. Proc Natl Acad Sci USA 87: 9568–9572.
9. Aihara H., Miyazaki J. I. (1998) Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16: 867–870.
10. Heller L. C., Ugen K., Heller R. (2005) Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2: 255–268.
11. Miller D. L., Pislaru S. V., Greenleaf J. E. (2002) Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet 27: 115–134.
12. Furth P. A., Shamay A., Wall R. J., Hennighausen L. (1992) Gene transfer into somatic tissue by jet injection. Anal Biochem 205: 365–368.
13. Vahlsing H. L., Yankauckas M., Sawdey S. H., Gromkowski M., Manthorpe M. (1994) Immunization with plasmid DNA using a pneumatic gun. J Immunol Methods 175: 11–22.
14. Rakhmilevich A. L., Turner J., Ford M. J., McCabe D., Sun W. H., Sondel P. H., Grota K., Yang N. S. (1996) Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci USA 93: 6291–6296.
15. Liu M. A., Ulmer J. B. (2000) Gene based vaccines. Mol Ther 1: 497–500.
16. Macklin M. D., McCabe D., McGregor M. W., Neumann V., Meyer T., Callan R., Hinshaw V. S. Swain W. F. (1998) Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J Virol 72: 1491–1496.
17. Turner J. G., Tan J., Crucian B. E., Sullivan D. M., Ballester O. F., Dalton W. S., Yang N. S., Burkholder J. K., Yu H. (1998) Broadened clinical utility of gene gun-mediated granulocyte-macrophage colony-stimulating factor cDNA-based tumor cell vaccines as demonstrated with a mouse myeloma model. Hum Gene Ther 9: 1121–1130.
18. Davis H. L., Demeneix B. A., Quantin B., Coulombe J., Whalen R. G. (1993) Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum Gene Ther 4: 733–740.
19. Heinzerling L., Burg G., Dummer R., Maier T., Oberholzer P. A., Schultz J., Elzaouk L., Pavlovic J., Moelling K. (2005) Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther 16: 35–48.
20. Zhang G., Vargo D., Budker V., Armstromg N., Knechtle S., Wolff J. A. (1997) Expression of naked plasmid DNA injected into afferent and efferent vessels of rodent and dog livers. Hum Gene Ther 8: 1763–1772.
21. Budker V., Zhang G., Danko I., Williams P., Wolff J. A. (1997) The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther 5: 272–276.
22. Liu F., Song Y. K., Liu D. (1999) Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258–1266.
23. Zhang G., Song Y. K., Liu D. (2000) Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using hydrodynamics-based procedure. Gene Ther 7: 1344–1349.
24. Pertmer T. M., Eisenbraun M. D., McCabe D., Prayaga S. K., Fuller D. H., Haynes J. R. (1995) Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T-lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13: 1427–1430.
25. Wells D. J. (2004) Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 11: 1363–1369.
26. McCreery T. P., Sweitzer R. H., Unger E. C., Sullivan S. (2004) DNA delivery to cells in vivo by ultrasound. Methods Mol Biol 245: 293–298.
27. Weller C., Linder M. (1966) Jet injection of insulin vs the syringe-and-needle method. JAMA 195: 844–847.
28. Baxter J., Mitragotri S. (2006) Needle-free liquid jet injections: mechanisms and applications. Expert Rev Med Devices 3: 565–574.
29. Mitragotri S. (2006) Current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov 5: 543–548.
30. Furth P. A., Kerr D., Wall R. (1995) Gene transfer by jet injection into differentiated tissues of living animals and in organ culture. Mol Biotechnol 4: 121–127.
31. Walther W., Stein U., Fichtner I., Voss K., Schmidt T., Schleef M., Nellessen T., Schlag P. M. (2002) Intratumoral low volume jet-injection for efficient nonviral gene transfer. Mol Biotechnol 21: 105–115.
32. Walther W., Stein U., Siegel R., Fichtner I., Schlag P. M. (2005) Use of the nuclease inhibitor aurintricarboxylic acid (ATA) for improved non-viral intratumoral in vivo gene transfer by jet-injection. J Gene Med 7: 477–485.
33. Heansler J., Verdelet C., Sanchez V., Girerd-Chambaz Y., Bonnin A., Trannoy E., Krishnan S., Meulien P. (1999) Intradermal DNA immunization by using jet-injectors in mice and monkeys. Vaccine 17: 628–638.
34. Choi A. H., Smiley K., Basu M., McNeal M. M., Shao M. Bean J. A., Clements J. D., Stout R. R., Ward R. L. (2007) Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection. Vaccine 25: 3215–3218.
35. Seigne J., Turner J., Diaz J., Hackney J., Pow-Sang J., Helal M., Lockhart J., Yu H. (1999) Feasibility study of gene gun mediated immunotherapy for renal cell carcinoma. J Urol 162: 1259–1263.
36. Yamashita Y., Shimada M., Hasegawa H., Minagawa R., Rikimaru T., Hamatsu T., Tanaka S., Shirabe K., Miyazaki J., Sugimachi K. (2001) Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res 61: 1005–1012.
37. Hui K. M., Chia T. F. (1997) Eradication of tumor growth via biolistic transformation with allogeneic MHC genes. Gene Ther 4: 762–767.
38. Walther W., Stein U., Fichtner I., Schlag P. M. (2001) In vivo gene transfer of naked DNA into xenotransplanted colon carcinoma by jet-injection. Langenbeck's Archives Surg 2001, 30: 69–72.
39. Walther W., Stein U., Fichtner I., Malcherek L., Lemm M., Schlag P. M. (2001) Non-viral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Ther 8: 173–180.
40. Walther W., Stein U., Fichtner I., Schlag P. M. (2004) Low-volume jet-injection for efficient in vivo gene transfer. Mol Biotechnol 28: 121–128.
41. Walther W., Stein U., Fichtner I., Aumann J., Arlt F., Schlag P. M. (2005) Nonviral jet-injection gene transfer for efficient in vivo cytosine deaminase suicide gene therapy of colon carcinoma. Mol Ther 12, 1176–1184.
42. Walther W., Arlt F., Stein U., Fichtner I., Schlag P. M. (2007) Heat-inducible in vivo gene therapy of colon carcinoma by human mdr1 promoter regulated TNF-α expression. Mol Cancer Ther 6: 235–243.
43. Stein U., Stege A., Walther W., Lage H. (2008) Complete in vivo reversal of the multidrug resistance (MDR) phenotype in a breast cancer model by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA. Mol Ther 16: 178–186.
44. Ren S., Li M., Smith J. M., DeTolla L. J., Furth P. A. (2002) Low-volume jet injection for intradermal immunization in rabbits. BMC Biotechnol 23: 10.
45. Cartier R., Ren S. V., Walther W., Stein U., Lewis A., Schlag P. M., Li M., Furth P. A. (2000) In vivo gene transfer by low-volume jet injection. Anal Biochem 282: 262–265.
Walther W., Siegel R., Kobelt D., Knösel T., Dietel M., Bembenek A., Aumann J., Schleef M., Baier R., Stein U., Schlag P.M. (2008) Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer. Clin Cancer Res 14: 7545–7553.
Acknowledgments
This work was kindly supported by the EMS Medical Systems SA, Nyon, Switzerland, and grants from the H.W. & J. Hector Foundation, Mannheim, Germany, and the Deutsche Forschungsgemeinschaft, Bonn, Germany. Support from A. Menne and T. Nellessen in the establishment of the jet-injection technology is appreciated. Help in the performance of the animal studies by M. Lemm and the excellent technical assistance of D. Kobelt, J. Aumann, and L. Malcherek are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Walther, W., Fichtner, I., Schlag, P.M., Stein, U.S. (2009). Nonviral Jet-Injection Technology for Intratumoral In Vivo Gene Transfer of Naked DNA . In: Walther, W., Stein, U. (eds) Gene Therapy of Cancer. Methods in Molecular Biology™, vol 542. Humana Press. https://doi.org/10.1007/978-1-59745-561-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-59745-561-9_11
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-934115-85-5
Online ISBN: 978-1-59745-561-9
eBook Packages: Springer Protocols